Literature DB >> 6827552

Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine.

N Bodor, H H Farag.   

Abstract

A dihydropyridine in equilibrium pyridinium salt type redox system is described as a general and flexible method for site-specific and sustained delivery of drugs to the brain. According to this, a biologically active compound linked to a lipoidal dihydropyridine carrier easily penetrates the blood-brain barrier. Oxidation of the carrier part in vivo to the ionic pyridinium salt prevents its elimination from the brain, while elimination from the general circulation is accelerated. Subsequent cleavage of the quaternary carrier-drug species results in sustained delivery of the drug in the brain and facile elimination of the carrier part. The concept is illustrated with phenethylamine as the drug and trigonelline as the quaternary carrier. One injection to rats of 1-methyl-3-(N-phenethylcarbamoyl)-1,4-dihydropyridine resulted in continuous build up in the brain of the corresponding 1-methyl-3-(N-phenethylcarbamoyl)pyridinium salt, reaching a maximum at about 80 min. At this time, the general circulation was practically void of either compound, while the accumulated carrier-drug species provided a source for sustained drug delivery only in the brain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6827552     DOI: 10.1021/jm00357a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  A redox-based system that enhances delivery of estradiol to the brain: pharmacokinetic evaluation in the dog.

Authors:  K Dietzel; V Keuth; K S Estes; M E Brewster; R M Clemmons; R Vistelle; N S Bodor; H Derendorf
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine.

Authors:  Lauri Peura; Kalle Malmioja; Kristiina Huttunen; Jukka Leppänen; Miia Hämäläinen; Markus M Forsberg; Mikko Gynther; Jarkko Rautio; Krista Laine
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

3.  Drug transport into the central nervous system: using newer findings about the blood-brain barriers.

Authors:  William A Banks
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

4.  Improved delivery through biological membranes. XXXVII. Synthesis and stability of novel redox derivatives of naproxen and indomethacin.

Authors:  M J Phelan; N Bodor
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

Review 5.  Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.

Authors:  M Mori; N Pimpinelli; B Giannotti
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

6.  High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats.

Authors:  G Mullersman; H Derendorf; M E Brewster; K S Estes; N Bodor
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

7.  Anxiolytic activity of a brain delivery system for GABA.

Authors:  W R Anderson; J W Simpkins; P A Woodard; D Winwood; W C Stern; N Bodor
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists.

Authors:  M C Maillard; O Nikodijević; K F LaNoue; D Berkich; X D Ji; R Bartus; K A Jacobson
Journal:  J Pharm Sci       Date:  1994-01       Impact factor: 3.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.